8:00 am Morning Refreshments & Check-In
9:00 am Workshop A
Navigating the Regulatory Landscape of Obesity Therapeutics to Understand How to Improve Patient Treatment
Synopsis
Learn about the evolving regulatory landscape for obesity medications, including clinical trial design, data requirements, and regulatory approval processes to drive your drugs towards clinic.
- Understanding the evolving regulatory guidelines and approval pathways for obesity medications, and how to measure obesity beyond BMI
- Gaining insights into the challenges and considerations for navigating the regulatory process
- Identifying strategies for optimizing clinical trial design and data collection to meet regulatory requirements
11:00 am Morning Break
11:30 am Workshop B
Exploring Precision Medicine Approaches to Obesity Treatment & How Patient Care Can be Personalised to Treat Obesity With Long-Term Success
Synopsis
Learn how to develop personalized treatment plans based on individual patient characteristics, including genetics, lifestyle, and other factors, to improve treatment outcomes and minimize side effects.
- Exploring the role of genomics, metabolomics, and other -omics technologies in identifying patient subgroups
- Discovering the potential for personalised treatment plans based on individual patient characteristic, lifestyles and lessons learnt from real world data
- Discussing the ethical and practical considerations of implementing precision medicine approaches in obesity care
1:30 pm Lunch
2:30 pm Workshop C
Navigating the Funding Process to Ensure the Success of Companies in Developing Treatments for Obesity & Weight Loss
Synopsis
Access insights into funding opportunities, investment strategies, and regulatory considerations for developing and bringing new obesity treatments to market to navigate the funding process
- Gaining insights into the evolving investor landscape and emerging trends in funding for this sector
- Understanding the key stages of the funding process, from seed funding to late-stage financing
- Understanding how to demonstrate a clear value proposition for drugs being developed to secure start up funding